We confirmed the key and central role of CDKN1C in this vulnerability through CRISPR knockout of CDKN1C which reversed the cell cycle arrest of DEX sensitive cancer cells while DOX-inducible constructs overexpressing CDKN1C in resistant NSCLC lines produced a strong growth inhibition phenotype. The gene discussed is CDKN1C; the disease is cancer.